Cross-trimester repeated measures testing for Down's syndrome screening: An assessment

Health Technology Assessment

Volumn 14, Issue 33, 2010, Pages 1-79

  Wright, D ^a   Bradbury, I ^b   Malone, F ^c   D'Alton, M ^d   Summers, A ^e   Huang, T ^e   Ball, S ^a   Baker, A ^a   Nix, B ^f   Aitken, D ^g   Crossley, J ^g   Cuckle, H ^h   Spencer, K ⁱ  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d Columbia University ^*  (United States)

^e NORTH YORK GENERAL HOSPITAL   (Canada)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^h UNIVERSITY OF LEEDS   (United Kingdom)

ⁱ KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ALGORITHM; ARTICLE; BLOOD SAMPLING; CANADA; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FALSE POSITIVE RESULT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; RISK ASSESSMENT; SCREENING; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; UNITED STATES;

ALGORITHMS; ALPHA-FETOPROTEINS; BAYES THEOREM; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; CONFIDENCE INTERVALS; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; MODELS, STATISTICAL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RISK ASSESSMENT; ROC CURVE;

EID: 77955149519     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta14330     Document Type: Article

References (35)

1. Mennuti MT, Driscoll DA. Screening for Down's syndrome - Too many choices? N Engl J Med 2003;349:1471-3.
2. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11.
3. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 1999;341:461-7.
4. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7(11).
5. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56-104.
6. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 2004;24:762-6.
7. Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, et al. Three-stage contingent screening for Down syndrome. Prenat Diagn 2006;26:528-34.
8. Wald NJ, Rudnicka AR, Bestwick JP. Sequential and contingent prenatal screening for Down syndrome. Prenat Diagn 2006;26:769-77.
9. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867-9.
10. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003;110:281-6.
11. Spencer K. Aneuploidy screening in the first trimester. Am J Med Genet C Semin Med Genet 2007. 145 C: p. 18-32.
12. Nicolaides KH. The 11-13+6 weeks scan. London: Fetal Medicine Foundation; 2004.
13. Wright DE, Bradbury I. Repeated measures screening for Down's syndrome. BJOG 2005;112: 80-3.
14. Wald NJ, Bestwick JP, Morris JK. Cross-trimester marker ratios in prenatal screening for Down syndrome. Prenat Diagn 2006;26:514-23.
15. Bossuyt P, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Clin Biochem 2003;40:357-63.
16. ONS. Birth statistics (2000-2002) Review of the registrar general on births and patterns of family building in England and Wales. Series FMI, nos 29-31.
17. Bayes T. An essay towards solving a problem in the doctrine of chances. Philos Trans R Soc Lond A 1764;53:370-418.
18. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphafetoprotein level. BJOG 1987;94:387-402.
19. Bray I, Wright DE, Davies C, Hook EB. Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn 1998;18:9-20.
20. Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;32:488-92.
21. Mardia KV, Kent JT, Bibby JM. Multivariate analysis. London: Academic Press; 1980.
22. Spencer K, Crossley J, Aitken DA, Nix ABJ, Dunstan FDJ, Williams K. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 2002;39:567-76.
23. Palomaki GE, Wright DE, Summers AM, Neveux LM, Meier C, O'Donnell A, et al. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: A validation study. Prenat Diagn 2006;26:730-9.
24. Aitchison J, Dunsmore IR. Statistical prediction analysis. Cambridge: Cambridge University Press; 1980.
25. Royston P, Thompson SG. Model-based screening by risk with application to Down's syndrome. Stat Med 1992;11:257-68.
26. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis. Second edition. Chapman & Hall/ CRC; 2004.
27. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Methods in health service research: An introduction to bayesian methods in health technology assessment. BMJ 1999;319:508-12.
28. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM, et al. Correction to SURUSS Report. J Med Screen 2006;13:51-2.
29. Wright D, Bradbury I, Benn P, Nix B, Spencer K, Cuckle H. CT ratios: parameter estimates are inconsistent with SURUSS publications? Prenat Diagn 2006;26:991-2.
30. Wald NJ, Bestwick JP, Morris JK. Cross trimester marker ratios: parameter estimates valid with no inconsistency. Prenat Diagn 2006;26:994.
31. Gilks W, Thomas A, Spiegelhalter DJ. A language and program for complex Bayesian modelling. Statistician 1994;43:169-77.
32. Berger JO, Rios Insua D, Ruggeri F. Bayesian robustness. In Rios Insua D, Ruggeri F, editors. Robust Bayesian analysis. New York, NY: Springer- Verlag; 2000.
33. Williams CJ, Lee SS, Fisher RA, Dickerman LH. A comparison of statistical methods for prenatal screening for Down's syndrome. Appl Stoch Model Bus Ind 1999;15:89-101.
34. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008;31:376-83.
35. Wald NJ, Rodeck C, Rudnicka A, Hackshaw A. Nuchal translucency and gestational age. Prenat Diagn 2004;24: 150-1.